Dermagarden
US$ 24.73
aa melanotic A Better Way to Distinguish Among Melanomas? Frontiers | Mucosal Melanoma: Pathological
Description
PFK-158, the first specific 6-phosphofructo-2-kinase (PFKFB3) inhibitor, has shown broad antitumor activity in a variety of human and preclinical models, and the clinical value of PFK-158 in patients with advanced pancreatic cancer has been reported in a related multicenter clinical trial (NCT02044861) [92]
Williams '90, P'21 Keith R
The dosage of the study agent or the placebo administered was two tablets taken orally, twice a day with food for 12 weeks
[DOI] [PubMed] [Google Scholar] Vermillion-Salsbury R
doi:10.1016/0005-2728(83)90122-6 Mikes V, Yaguzhinskij LS
Carol Publishing Group
